Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1 Moderna, Inc Aug 24, 2024 08:00 HKT/SGT Read More
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024 Avantor Aug 23, 2024 08:00 HKT/SGT Read More
"LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in the United Arab Emirates Eisai Aug 14, 2024 08:59 HKT/SGT Read More
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results Sino Biopharmaceutical Limited Aug 14, 2024 00:30 HKT/SGT Read More
Q&M Dental Group's profit after tax grew 84%, Board declared 0.40 cent interim dividend, a 150% increase over the same period last year Q&M Dental Group Ltd Aug 12, 2024 15:00 HKT/SGT Read More
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines NEC Corporation Aug 08, 2024 10:12 HKT/SGT Read More
Eisai: Update Regarding the Regulatory Status of LEQEMBI Subcutaneous Formulation Eisai Aug 06, 2024 12:15 HKT/SGT Read More
New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer's Disease Patients Presented at AAIC 2024 Eisai Jul 31, 2024 12:59 HKT/SGT Read More
Dual-action therapy shows promise against aggressive oral cancer Science and Technology of Advanced Materials Jul 30, 2024 20:00 HKT/SGT Read More